Distriphil and QuidelOrtho FORGES partnership TO PROVIDE HIGH QUALITY HEALTHCARE
Distriphil and QuidelOrtho established a strategic partnership which aims to elevate healthcare accessibility across the country. By leveraging on Distriphil’s extensive distribution network and QuidelOrtho’s[…]
Distriphil wins APEA Corporate Excellence Award for Healthcare, Pharmaceutical & Biotechnology Industry
Last October 20, 2022, Distriphil was awarded the Corporate Excellence Award for Healthcare, Pharmaceutical & Biotechnology category of the Asia Pacific Enterprise Awards (APEA) Regional[…]
Distriphil holds occupational first aid training in partnership with Philippine Red Cross
“OCCUPATIONAL FIRST AID TRAINING AT DISTRIPHIL–A STEP TOWARD A SAFER WORKPLACE” Discover how the two-day Occupational First Aid and Basic Life Support Training done in[…]
Copyright © 2019 DistriPhil | All rights reserved.
Stay Connected
Get in Touch
3rd Floor Alexcy One Building, #51 President’s Avenue, BF Homes, Paranaque City.
Phone: (02) 8801 3092
Email: info@distriphil.com
© 2024 Distriphil. Created for free using WordPress and Kubio
FOR SUSPECTED ADVERSE REACTIONS please report to the Food and Drug Administration (Philippines) at www.fda.gov.ph and to the DISTRIPHIL Pharmacovigilance Unit through email address drugsafety@distriphil.com or you may call or text our 24/7 Pharmacovigilance Hotline at +63-949-884-5386 (Smart). AT THE FIRST SIGN OF AN ADVERSE REACTION, PLEASE SEEK MEDICAL ATTENTION IMMEDIATELY.